Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 23, 2011

View Archived Issues

Korean scientists synthesize novel protein kinase inhibitors

Phase II trial of antisense drug iCo-007 begins in the U.S.

Public gene expression data used to reposition drugs for new indications

SRT-1720 has beneficial effects in obesity model

New genetic variants in multiple sclerosis identified

Advinus Therapeutics discloses novel glucokinase activators

New immunosuppressants disclosed by Daiichi Sankyo

Chinese researchers patent novel anticancer agents

Pfizer synthesizes novel tyrosine-protein kinase inhibitors

Australian research team patents novel agents for RSV infection

Vertex designs novel series of protein kinase inhibitors

Fresolimumab receives orphan drug designation in the E.U.

Delcath reports data from phase II trial of its chemosaturation system

Isconova announces expansion of vaccine collaboration with Genocea

Cell Therapeutics submits response to questions raised by EMA regarding pixantrone MAA

Mesoblast performs first lumbar disc procedure in phase II stem cell trial

Incivek obtains approval in Canada for hepatitis C

Mayo Clinic obtains IND clearance for ovarian and breast cancer vaccine trials

First patient enrolled in phase I/II study of Hemispherx's Ampligen in breast cancer

Symphogen begins phase II trial of Sym-004 in head and neck cancer

AstraZeneca launches Brilinta in the U.S. for patients with ACS

Bayer gains FDA fast track designation for Alpharadin

Nippon Kayaku files for approval of additional dosages and indications for Randa and Lastet in Japan

BioDelivery Sciences plans commercial launch of Onsolis in Canada

Cres Pharmaceuticals compound obtains orphan status for primary myelofibrosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...